Design Therapeutics, Inc. DSGN
$10.71
▲ +4.18% 24H
About
Design Therapeutics Inc. is a biotechnology company focused on developing treatments for serious degenerative disorders. At the heart of its operations is the use of a proprietary technology platform aimed at addressing the underlying genetic causes of such conditions. Design Therapeutics specializes in creating what t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees54
TickerDSGN
Statistics
Market Cap$668.7M
Revenue (TTM)$0
Net Income-$69.8M
Net Margin—
EPS$-1.22
P/E-9.01
P/S—
P/B3.02
EV/EBITDA-5.63
ROE-31.3%
Dividend Yield—
Price$10.71
Data: Twelve Data · Revenue = mcap / P/S